Sensorion SA (EPA:ALSEN)
France · Delayed Price · Currency is EUR 0.3160
+0.0110 (3.61%)
At close: Feb 20, 2026
Sensorion Market Cap
Sensorion has a market cap or net worth of €94.91 million as of February 20, 2026. Its market cap has decreased by -49.68% in one year.
Market Cap
94.91M
Enterprise Value
39.39M
Revenue
5.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.32
Market Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 94.91M, an increase of 363.96%. That is a compound annual growth rate of 15.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 94.91M | -6.27% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 252.42M |
| Transgene | 221.80M |
| MaaT Pharma | 143.76M |
| Innate Pharma | 136.05M |
| Adocia | 134.21M |
| ABIONYX Pharma | 122.77M |
| OSE Immunotherapeutics | 98.11M |
| Valerio Therapeutics Société anonyme | 73.08M |